Amrutanjan Health Care Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amrutanjan Health Care Limited with three other companies in this sector in INDIA : Kopran Limited (2020 sales of 3.59 billion Indian Rupees [US$49.14 million] of which 51% was Bulk Drugs), Albert David Limited (3.20 billion Indian Rupees [US$43.73 million] of which 100% was manufacturing of pharmaceuticals), and Ngl Fine Chem Ltd (1.52 billion Indian Rupees [US$20.74 million] of which 100% was Pharmaceticals).

Sales Analysis. During the year ended March of 2020, sales at Amrutanjan Health Care Limited were 2.61 billion Indian Rupees (US$35.74 million). This is an increase of 3.3% versus 2019, when the company's sales were 2.53 billion Indian Rupees . This was the fifth consecutive year of sales increases at Amrutanjan Health Care Limited (and since 2015, sales have increased a total of 66%). Sales of Others saw an increase that was more than double the company's growth rate: sales were up 38.5% in 2020, from 17.34 million Indian Rupees to 24.01 million Indian Rupees . Amrutanjan Health Care Limited also saw significant increases in sales in Otc Products (up 4.4% to 2.41 billion Indian Rupees ) . Not all segments of Amrutanjan Health Care Limited experienced an increase in sales in 2020: sales of Beverages fell 11.9% to 182.99 million Indian Rupees .